(CercleFinance.com) – Néovacs announces a fundraising of 1 ME by drawing 1 tranche of OCEANE-BSA, with a nominal value of 1,000,000 E, subscribed by European High Growth Opportunities Securitization Fund.
Neovacs specifies that the net proceeds of this operation (i.e. 960,000 E) will be half intended to finance the Kinoid research program on allergies and the other half to strengthen investment capacities in promising projects, both in the development of drug candidates (BioTech) and medical devices (MedTech).
To date, the drawdown of 16 tranches of OCEANE-BSA bonds and 4 tranches of commitment fees has raised €15.4m, resulting in the creation of 13,982,196,311 new shares.